Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1046 of 1,261
  1. US 7456199

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  2. US 7456203

    Muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  3. US 7455994

    Methods for producing Marburg virus proteins

    The United States of America as represented by the Secretary of the Army · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  4. US 7455964

    Genes from the 20q13 amplicon and their uses

    The Regents of the University of California · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  5. US 7456268

    Materials and methods for inhibiting Wip1

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  6. US 7456297

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  7. US 7455845

    Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure

    The Regents of the University of Colorado · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  8. US 7456180

    Piperazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  9. US 7456190

    Compositions useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  10. US 7456222

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  11. US 7456162

    Benzofuran derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  12. US 7455833

    Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  13. US 7452548

    Conjugated linoleic acid compositions

    Aker Biomarine AS · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  14. US 7452679

    Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof

    Northwestern University · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  15. US 7452971

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  16. US 7452681

    Diagnostic methods for the detection of autism spectrum disorder

    The Regents of the University of California · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  17. US 7452544

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  18. US 7452538

    Death domain containing receptor 4 antibodies and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  19. US 7452723

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  20. US 7452887

    Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

    Amphora Discovery Corporation · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  21. US 7452873

    Inhibitors of GSK-3 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  22. US 7452865

    Antagonistic analogs of GH RH (2003)

    United States of America by Dept of Veterans Affairs · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  23. US 7452861

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted
  24. US 7452879

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.